Stock Upgrades Today Show Top Picks

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  09 Dec 2025
 

•   AAL  
   
  +0.07%
•   AAPL  
   
  -0.19%
•   ACCO  
   
  -0.28%
•   ADI  
   
  -0.04%
•   ADT  
   
  +0.25%

$AAL BMO Capital initiated coverage of American Airlines Group with a Market Perform recommendation, signaling modest upside potential as the airline continues its recovery in passenger demand and operational efficiency. Investors can watch for momentum around holiday travel peaks.

$AAPL Evercore ISI Group and Wedbush both maintain Apple Outperform recommendations, highlighting continued confidence in the tech giant’s growth and ecosystem dominance, even amid slight near-term volatility.

$ACCO Barrington and Noble Financial maintain Buy ratings on ACCO Brands, recognizing it as an affordable stock under $5 with multi-year growth potential driven by cost-efficient operations and steady product demand.

$ADI UBS maintains a Buy recommendation on Analog Devices, emphasizing its consistent performance in semiconductors and resilience in industrial and automotive demand segments.

$ADT ADT upgraded to Buy by Zacks, reflecting optimism about recurring revenue growth and potential upside from new security technology offerings in residential and commercial markets.

$AFRM Wolfe Research initiates coverage of Affirm Holdings with Peer Perform, noting significant upside potential driven by fintech expansion and consumer credit adoption trends.

$ALIT D.A. Davidson reiterates Buy rating on Alight, underscored by leadership change and strong positioning in technology-driven HR solutions for enterprise clients.

$ALSN Raymond James upgraded Allison Transmission Holdings to Strong Buy, emphasizing the company’s robust industrial demand and strategic growth in hybrid and electric drivetrains.

$ANET UBS maintains Buy rating on Arista Networks, signaling continued confidence in its networking hardware and software performance amid mixed analyst opinions.

$APGE TD Cowen and Canaccord Genuity maintain Buy on Apogee Therapeutics, noting the strong pipeline and potential to capitalize on 52-week high momentum in biotech innovation.

$APTV Morgan Stanley upgrades Aptiv to Equal-Weight, highlighting a rebound potential in automotive technology and electrification solutions, with notable upside over the coming months.

$ASGN BMO Capital maintains Buy on ASGN, pointing to attractive small-cap valuation and stable demand in staffing and workforce solutions sectors.

$AVAV RBC Capital maintains Outperform on AeroVironment, signaling substantial upside potential as defense and drone technologies continue expanding globally.

$AX DA Davidson maintains Buy on Axos Financial, highlighting fintech and digital banking trends contributing to strong growth prospects.

$BIOA Morgan Stanley upgrades BioAge Labs to Equal-Weight, reflecting investor caution as near-term valuation pressures offset long-term aging and longevity tech prospects.

$BTSG William Blair initiates coverage of BrightSpring Health Services with Outperform, recognizing the growing demand in healthcare support services and post-acute care.

$BWAY HC Wainwright maintains Buy on BrainsWay, noting that the stock remains highly speculative, with substantial downside potential despite its innovative neurostimulation therapies.

$CAPR Oppenheimer maintains Outperform on Capricor Therapeutics, underscoring biotech growth opportunities driven by promising therapeutic pipelines.

$CENT KeyBanc and Canaccord maintain Buy on Central Garden & Pet Company, emphasizing steady revenue in consumer-focused small-cap segments.

$CHE Chemed upgraded to Buy, reflecting strong earnings prospects in home healthcare and plumbing service operations.

$CL RBC Capital upgrades Colgate-Palmolive to Outperform, signaling stable consumer brand demand and international growth opportunities.

$COF Wolfe Research initiates coverage of Capital One Financial with Outperform, highlighting solid credit growth and banking profitability in the current economic environment.

$COHR Raymond James maintains Strong Buy on Coherent Corp, pointing to underappreciated AI exposure driving continued upside in optical components and photonics.

$CVLT Mizuho initiates coverage of Commvault Systems with Outperform, highlighting substantial upside in data protection and cloud management solutions.

$CVNA B of A Securities maintains Buy on Carvana, noting modest near-term upside as used vehicle market dynamics stabilize.

$CVS CVS Health updates 2025 and 2026 guidance with strong revenue and earnings growth projections, signaling the stock as a resilient healthcare investment.

$DAL BMO Capital initiates coverage of Delta Air Lines with Outperform, highlighting potential upside from fleet modernization and loyalty program expansion.

$DBRG RBC Capital maintains Outperform on DigitalBridge Group, noting strong opportunities in digital infrastructure and data center investments.

$DVN JP Morgan upgrades Devon Energy to Overweight, emphasizing strong energy pricing and operational efficiency contributing to robust upside potential.

$ETN Wolfe highlights stronger 2026 growth for Eaton, reflecting industrial upgrades and expansion into energy-efficient solutions.

$FIVE Truist Securities upgrades Five Below to Buy, signaling confidence in continued retail momentum and consumer discretionary growth.

$GM Morgan Stanley upgrades General Motors to Overweight, noting ongoing innovation in EVs and autonomous vehicle initiatives despite minor near-term downside.

$GPRK GeoPark maintains Moderate Buy, highlighting upside potential in affordable oil stocks under $10 with strategic production plans.

$HD Citi maintains Buy on The Home Depot, reflecting solid demand in home improvement and potential rebound after Q3 mixed earnings.

$IBM Erste Group upgrades IBM to Buy, citing strong Q3 performance and growth driven by Red Hat acquisitions and AI enterprise solutions.

$INCY Mizuho upgrades Incyte to Outperform, noting biotechnology growth and strong pipeline developments despite modest near-term downside.

$ING ING upgraded to Buy, highlighting optimism about earnings prospects and resilient financial performance across European markets.

$JEF Morgan Stanley upgrades Jefferies Financial Group to Overweight, emphasizing upside in financial services and investment banking operations.

$JKHY Keefe Bruyette & Woods upgrades Jack Henry & Associates to Outperform, reflecting steady fintech solutions growth for banking clients.

$KMDA HC Wainwright maintains Buy on Kamada, signaling substantial upside potential in biopharmaceutical development.

$KYMR BTIG maintains Buy on Kymera Therapeutics, noting high-risk biotech potential but some near-term downside pressure.

$LEGN UBS maintains Buy on Legend Biotech, highlighting extraordinary upside potential driven by biopharmaceutical innovations.

$META Arete Research upgrades Meta Platforms to Buy, pointing to steady performance and potential upside in social media and AI-driven advertising growth.

$MIR Citigroup maintains Buy on Mirion Technologies, reflecting growth potential in radiation detection and safety solutions.

$MSBI Keefe Bruyette & Woods maintains Market Perform on Midland States Bancorp, noting mild downside potential despite stable operations.

$MSFT D.A. Davidson maintains Buy on Microsoft, highlighting continued dominance in cloud computing and enterprise software, with moderate near-term retracement.

$MSI Northcoast Research upgrades Motorola Solutions to Buy, emphasizing security and communications technology growth opportunities.

$MTDR Citigroup initiates coverage of Matador Resources with Buy, noting solid upside potential in energy production and operational efficiency.

$MU HSBC and BofA Securities initiate and upgrade Micron to Buy, highlighting strong growth in semiconductor memory markets and AI-driven demand.

$NB HC Wainwright maintains Buy on NioCorp Developments, emphasizing extraordinary upside potential in critical minerals and specialty materials.

$NBIX RBC Capital maintains Outperform on Neurocrine Biosciences, citing strong pipeline growth and near-term upside.

$NCLH Truist maintains Buy on Norwegian Cruise Line Holdings, signaling long-term recovery potential in travel and leisure.

$NFLX Needham and Canaccord maintain Buy on Netflix, noting strong upside potential from streaming dominance and content expansion.

$NRG UBS initiates Buy on NRG Energy, highlighting valuation and cash flow strength in the energy sector.

$NTRA Canaccord maintains Buy on Natera, pointing to moderate downside but solid long-term growth in genetic testing.

$NUVL Truist initiates Buy on Nuvalent, citing promising lung cancer treatment developments driving near-term upside potential.

$NVS JP Morgan upgrades Novartis to Overweight, reflecting modest upside in a stable pharmaceutical leader.

$OCUL HC Wainwright and Needham maintain Buy on Ocular Therapeutix, noting exceptional upside in ophthalmic treatments.

$OMF Truist initiates coverage of OneMain Holdings with Buy, reflecting steady growth in personal lending solutions.

$PH Citigroup maintains Buy on Parker-Hannifin, highlighting consistent industrial performance and moderate upside potential.

$PRKS Truist maintains Buy on United Parks & Resorts, noting long-term potential despite short-term price target adjustment.

$PWR JP Morgan upgrades Quanta Services to Overweight, highlighting steady growth in energy infrastructure and engineering services.

$RAL Citigroup upgrades Ralliant to Buy, emphasizing upside potential in specialty chemicals and performance materials.

$RBRK Citigroup maintains Buy on Rubrik, highlighting cloud data management solutions with strong upside potential.

$RIVN Rivian Automotive upgraded to Buy by Zacks, signaling optimism in EV growth prospects and increasing production capacity.

$RL Ralph Lauren gains momentum as digital acceleration and strategic initiatives drive steady retail growth.

$RMNI Alliance Global Partners maintains Buy on Rimini Street, highlighting tech solutions expansion and market penetration.

$ROK Citigroup maintains Buy on Rockwell Automation, signaling modest downside but stable industrial automation growth.

$SLG Evercore ISI and BMO Capital maintain Outperform on SL Green Realty, highlighting strong upside in commercial real estate opportunities.

$SLVM Bank of America Securities maintains Buy on Sylvamo Corporation, emphasizing value in small-cap paper and packaging markets.

$SNOW Citigroup maintains Buy on Snowflake, highlighting cloud data growth opportunities and significant upside potential.

$SNPS Rosenblatt maintains rating upgrade on Synopsys, reflecting optimism ahead of Q4 IP and China market rebound.

View All Headlines